Remove Government Remove Leads Remove Networking Remove Physicians
article thumbnail

What if Bill Clinton & Ronald Reagan Had Debates Universal Government Funded Healthcare? A Fictional Debate Portrayal.

Pharma Marketing Network

Bill Clinton: My fellow Americans, I stand here today to argue in favor of universal government-funded healthcare. This leads to higher healthcare costs for everyone, as emergency room visits and hospital stays are much more expensive than regular doctor visits. appeared first on Pharma Marketing Network.

article thumbnail

Webinar recap: How Cigna is Innovating their Network Design Process

Clarify Health

On December 16th, we hosted an AHIP webinar discussion about how Cigna is innovating their network design process for market expansion. Austin has spent the last eight years at Cigna with responsibility for medical economics and analytics, leading the transformation of data and analytics for their government business segment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Five Ways ASCs Can Use Price Transparency to Strengthen Their Market Position

Clarify Health

As both government and commercial payers direct a greater share of volume to out-patient facilities and patient demand for same-day service increases, opportunity and competition in the ambulatory surgical center (ASC) space are increasing.

article thumbnail

What health plans should know about healthcare price transparency

Clarify Health

No surprise billing: A breakdown of the key requirements and deadlines in the No Surprises Act The No Surprises Act aims to protect patients from receiving “surprise” (or unexpected) medical bills from a healthcare provider or facility after inadvertently receiving care from an out-of-network provider.

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

While maintaining a vigilant approach to marketing compliance is crucial, the FDA may be strategically choosing to address more immediate public health concerns, leading to fewer marketing violation letters being issued. appeared first on Pharma Marketing Network. The post Why Is FDA Issuing Fewer Marketing Violation Letters?

article thumbnail

News release: Clarify Health unlocks greater clinical trial diversity with launch of Clarify Trials

Clarify Health

These data are linked to government and commercial claims, clinical, prescription and dispensing data, covering over 300 million patient lives. The research firm cited that Clarify “is in a prime position to lead RWE IT solutions in life sciences.” To learn more about Clarify Trials, visit [link].

article thumbnail

Why healthcare organizations need business intelligence tools today

Clarify Health

That information can lead to data-driven decisions about where is best to invest for future needs, or what can be safely scaled back. Physician engagement is another area ripe to spur growth. Transparently showing physicians the data leaders to better engagement and can help drive behavior change.